INTRODUCTION
Dendritic cells (DC) are potent antigen presenting cells which have an unique ability to prime naive T cells 1 . Additionally, they secrete immune-modulating factors that play a key role in the initiation and regulation of both innate resistance and adaptive immunity. DC undergo striking changes in function and morphology depending on their maturation state and localization 1 . Immature DC, located in peripheral tissues, are considered as immune sentinels and are able to capture and process antigen 2 . Upon activation and maturation induced by pro-inflammatory signals, such as pathogen-associated molecular patterns (PAMP) 3 , they migrate to the T cell areas of secondary lymphoid organs, where they are able to present antigen to naive T cells 4, 5 . The outcome of the immune response (either immune priming or tolerance) is directly linked to the maturation status of DC 6 , which is generally believed to be induced by endogenous factors such as pro-inflammatory cytokines (TNF or IL-1β) 7, 8 or by exogenous products such as PAMPs (e.g. LPS, LTA or viral-RNA mimics e.g. poly(I:C)) 9 .
DC activity can be regulated by both activating and inhibiting immune receptors that transduce signals through immunoreceptor tyrosine-based activating motifs (ITAM, consensus: D/Ex 7 D/Ex 2 Yx 2 L/Ix 7 Yx 2 L/I) 10, 11 and through immunoreceptor tyrosine-based inhibitory motifs (ITIM, consensus: I/V/L/SxYx 2 L/V) 12, 13 , respectively. This growing family of receptors was first described in lymphocytes [14] [15] [16] , but in recent years an increasing number of receptors of the lectin and the Immunoglobulin Superfamilies (IgSF) linked to ITAM/ITIM signalling expressed on myeloid cells and DC has been described 17, 18 . These data indicate that cells of the myeloid lineage have a large number and variety of receptors regulating their activity. These receptors signal through activating or inhibiting pathways that regulate the amplitude and the duration of the immune response triggered by pathogenic stimuli [19] [20] [21] .
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We recently described hOSCAR, a novel immune receptor associated with the Fc receptor γ-chain (FcRγ) and involved in endocytosis and antigen presentation through the MHC class II pathway in monocyte-derived dendritic cells (mono-DC) 22 . Its association with an ITAM-bearing chain confers to hOSCAR the capacity to activate myeloid cells as shown by its ability to trigger calcium flux and cytokine release 22 . As hOSCAR is expressed by both immature and LPS-matured mono-DC, we proposed that hOSCAR may have a biological role on human DC probably different to the previously described activating receptors such as the Fc receptors (FcR) and TREM-2, the expression of which is down-regulated after activation of DC. In contrast to the human receptor, mouse OSCAR (mOSCAR) is only expressed on osteoclasts 23 , which are derived, like certain DC subsets, from the myeloid lineage 24 . Data from different groups strongly suggest that in vivo ligation of mOSCAR on osteoclasts is essential for differentiation of these cells. An endogenous ligand for OSCAR on osteoblasts has been inferred from this work 23, 25 . Of interest, TREM-2, an activating receptor that uses the ITAM-bearing adapter DAP12, was first described in DC and shown to promote cell survival and a partial maturation phenotype 26 . TREM-2 has also been shown to be involved in osteoclast differentiation and function [27] [28] [29] . These data underline the relevance of receptors associated with either FcRγ or DAP12 in the biology of cells of the myeloid lineage, including osteoclasts and DC.
In this study we show that hOSCAR ligation induces phenotypical and functional maturation of DC. Cytokine and chemokine secretion was induced in DC by hOSCAR ligation, although no significant effect was noted on the ability of the treated DC to prime naive T cell proliferation. However, when hOSCAR ligation was associated with treatment by certain Toll-like receptor (TLR) ligands, the ability of DC to support naive T cell proliferation was synergistically amplified. Finally, the inflammatory effects in DC of the TLR4-ligand LPS, but not those of the TLR7/8-ligand R-848 and of the TLR3-ligand poly(I:C), were attenuated
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For
MATERIALS AND METHODS

Cell culture
Mono-DC were produced by culturing purified blood monocytes for 5 days in the presence of 200 ng/ml rhGM-CSF (Schering-Plough Research Institute, Kenilworth, NJ) and 10 ng/ml rhIL-4 (Schering-Plough Research Institute), as previously described 22 . Blood naive CD4 + CD45RA + T cells were prepared from PBMC by two round of negative selection using magnetic beads (Dynal). The depletion was performed with anti-CD45RO (UCHL1), -CD8, -14, -CD19, -CD40 (89), -HLA-DR (L243), (all ascites from our laboratory), purified anti-CD56, -CD16, -CD35, -glycophorin A (all from Immunotech).
Purity of the preparation was controlled by flow cytometer analysis of double labeling with anti-CD3-FITC (Dako) and anti-CD45RA-PE (Beckman Coulter) and was ≥96%.
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In vitro stimulation of mono-DC
Anti-hOSCAR mAb and F(ab') 2 fragments mAb were produced by as previously described 22 .
Anti-hOSCAR mAb and F(ab') 2 (clone 11.1CN5), and irrelevant mAb MOPC21 (Sigma) or anti-CD13 (Immunotech) as isotype controls were coated for 4 h at 37°C on flat-bottom plates with a final concentration of 20 µg/ml in PBS. Immature DC were plated at a concentration of 1 x 10 6 cells/ml. The following activating factors were used at final concentrations of 20 ng/ml rhTNF (Genzyme, Boston, MA), 10 ng/ml E. coli lipopolysaccharide (LPS) (Sigma), 25 µg/ml polyinosinic-polycitidylic acid, (poly(I:C), InvivoGen, San Diego, CA), 10 µM R-848 (imidazoquinoline resiquimod synthesized in our laboratory Schering-Plough).
Supernatants and cells were collected after 24 h and tested by ELISA and flow cytometry, respectively. All mAb used for tissue culture were shown to be endotoxin free, as determined by Limulus-Amebocyte Assay (BioWhittaker, Walkersville, MD). To block the effect of LPS, polymixin B (Sigma) was added to the culture at 10 µg/ml.
Flow cytometry
Cell staining was performed using PE-conjugated mouse mAb anti-CD54 (Bioscience),
anti-CD40, -CD83, -DC-LAMP (Immunotech), anti-CD25, -CD80, -CD86, -HLA-DR (BD PharMingen) and FITC-conjugated mouse mAb anti-CCR7 (BD PharMingen). The staining with anti-DC-LAMP was performed using the cytofix/cytoperm kit (BD PharMingen).
Incorporation of FITC-dextran
Mono-DC were harvested after 48-h of stimulation, as described above, resuspended in complete medium supplemented with 25 mM Hepes (Life Technologies, Paisley Park, UK) and incubated at 4 or 37°C. FITC-dextran (M r = 40,000 kDa ; Molecular Probes Eugene, OR) was added at a final concentration of 100 µg/ml for 30 min. The cells were washed four times
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The maturation of mono-DC was assessed by staining with PE-conjugated mouse mAb anti-CD86 (BD Pharmingen).
Detection of apoptosis
After mono-DC differentiation, the cells were harvested and washed four times in PBS to remove GM-CSF and IL-4. Mono-DC stimulated with coated mAb for 3 days were harvested and the apoptotic cells were detected using the FITC-annexin V kit (BD Pharmingen).
To measurement mitochondrial membrane potential, cells were incubated in complete medium containing 25 nM 3,3-Dihexyloxocarbo-cyanine iodide (DiOC 6 (3) (Molecular Probes, Eugene, OR) for 30 min at 37°C in the dark followed by flow cytometer analysis.
Intracellular labelling with FITC-conjugated mouse mAb anti-Bcl-2 (Dako) or with rabbit polyclonal Ab anti-Bcl-x (BD Biosciences), followed by PE-conjugated goat anti-rabbit (Sigma) were performed as described elsewhere 30 . In blocking experiments, inhibitors (10 µM LY294002, 10 µM wortmannin, 20 µM PD98059, all from Calbiochem) were added 60 min before stimulation.
For biochemical analysis, mono-DC were stimulated as described above. After 3 days, cells were harvested and lysed in reducing sample buffer, and cell lysates were analysed by SDS-Page and reducing Western blot, as previously described 22 . The Bcl-x isoforms were detected using polyclonal Ab anti-Bcl-x and donkey anti-rabbit conjugate (Vector, Burlingame, CA).
Measurement of mono-DC secreted cytokines and chemokines
Supernatants of cells stimulated for 24 h were collected and tested by ELISA for production of IL-1β, IL-6, IL-8/CXCL8, IL-10, IL-12 p40, IL-12p70, TNF, MCP-1/CCL2, 
Semi-quantitative RT-PCR
Cells were lysed and total RNA was extracted using the RNeasy kit (Qiagen, Maryland). To study the polarization of naïve T lymphocytes, 1.10 6 /ml CD45RA + T cells were cultured with 1.10 5 /mL mono-DC stimulated as described above. At 5 days, human rIL-2 (a generous gift from Dr. C. Caux-Menetrier) was added at 10 U/ml, and the cells were expanded for 9
days. The quiescent T cells were then stimulated with 50 ng/ml PMA and 2 µg/mL ionomicin Proteins from the Bcl-2 family, particularly Bcl-2 and the Bcl-x L isoform, are known cell death antagonists 33, 34 , whereas the shorter Bcl-x S isoform has an opposite role. The survival effect of hOSCAR, as well as that of the positive controls TNF and GM-CSF, was characterised at day 3 by concomitant expression in mono-DC of Bcl-2 and Bcl-x, as shown by intracellular staining (Fig. 1C) . As shown by Western blot, the staining for Bcl-x was mainly due to the presence of the anti-apoptotic long isoform Bcl-x L of 28kDa (Fig. 1D ).
Treatment of mono-DC with the ERK inhibitor PD98059 and the two phosphoinositide-3-OH-kinase (PI3K) inhibitors, LY294002 ( 
hOSCAR ligation up-regulates the maturation marker expression on DC
Immature mono-DC were stimulated by LPS or by mAb coated onto culture plates, an efficient way of cross-linking the appropriate receptors 32 . After 24-h stimulation, phenotypical analysis of these cells was performed by flow cytometry (Fig. 2 ).
Both coated F(ab') 2 and whole mAb anti-hOSCAR were able to trigger the activation of mono-DC as shown by up-regulation of the co-stimulatory molecule CD86 ( Fig. 2A) . The up-regulation of CD86 expression induced by F(ab') 2 and whole anti-hOSCAR was consistently observed but of lower intensity compared to that observed in mono-DC activated by LPS. Unlike anti-hOSCAR, the two isotype-matched controls, MOPC21 (irrelevant mAb) or anti-CD13 (a known DC surface receptor), had no significant effect on the activation state of mono-DC. Cross-linking of hOSCAR was required for the triggering of activation, since no effect was observed with soluble mAb. All mAb used in this study were negative for endotoxin contamination as measured by the Limulus assay. The activating effect of anti-hOSCAR was maintained in the presence of polymixin B and absent when soluble mAb was used, excluding any role of undetectable levels of endotoxins ( Fig. 2A) .
Upon hOSCAR ligation on mono-DC, we also observed up-regulation of CD40, CD80 and HLA-DR, and slightly increased expression of CD54 (Fig. 2B) . In addition, a subpopulation of mono-DC stimulated by anti-hOSCAR up-regulated CD83 and the intracellular maturation marker DC-LAMP. With some donors (2 out of 5), a slight up-regulation of CCR7 was also observed (data not shown).
The activating ability of hOSCAR was then studied on freshly isolated blood CD11c + DC (Fig. 2C ). hOSCAR ligation triggered slight up-regulation of CD80, and an increase of CD86
and CD83 expression. The increase in CCR7 expression, upon hOSCAR crosslinking, was higher and more reproducibly observed on CD11c + DC than on mono-DC.
hOSCAR stimulation enhanced the ability of the TLR ligands LPS, R-848, and poly(I:C) to induce DC maturation and up-regulation of co-stimulatory marker expression (CD25, CD80, CD83, CD86) (Fig. 3 ), but no alteration in the levels of HLA-DR, CD40, and CD54 (data not shown) were seen. This effect was more pronounced when sub-optimal doses of TLR ligands were used and the increase of expression was particularly high with poly(I:C), a less potent mono-DC stimulator, than with LPS and R-848. Nevertheless the up-regulation of expression is moderate, and may be due to an additive effect between ITAM and TLR signalling.
Maturation of mono-DC by anti-hOSCAR decreases their ability to uptake FITCdextran
The ability to internalise and process antigen is a constitutive property of immature DC that has been shown to decrease upon cellular maturation 7 . In our experiments the majority of mono-DC, cultured alone or in the presence of the isotype controls MOPC21 and anti-CD13, were positive for FITC-dextran uptake (80.5% ± 6.7, 74.2% ± 10.7, and 84.6 ± 6.1, respectively) (Fig. 4B) , and negative for CD86 expression (Fig. 4A) . The percentage of FITC-dextran positive cells decreased upon DC maturation (Fig. 4A) . Almost all the LPS-matured mono-DC strongly expressed CD86 and were unable to uptake FITC-dextran.
After treatment with anti-hOSCAR or TNF, a 39.9% ± 8.3 and a 59.3% ± 5.3 reduction, respectively, in dextran-positive mono-DC was observed (p<0.001). After stimulation of mono-DC by anti-hOSCAR and TNF two populations were identifiable: CD86-negative cells that were still able to incorporate FITC-dextran and fully matured CD86-positive mono-DC that had no macropinocytic/endocytic activity.
hOSCAR activation induces the secretion of cytokines and chemokines
We investigated the ability of hOSCAR ligation on mono-DC to trigger cytokine and chemokine secretion ( Table 1) . Stimulation of this receptor triggered production of high amounts of IL-8/CXCL8 (Fig. 5 ), which were not produced in response to isotype controls (MOPC21 anti-CD13) or soluble anti-hOSCAR. Coated F(ab') 2 and whole anti-hOSCAR mAb in the presence of polymixin B were able to trigger the activation of DC as potently as the whole mAb, demonstrating that the activation observed was not mediated by FcR engagement or by contaminating endotoxin (Fig. 5A ). hOSCAR ligation also induced secretion of M-CSF and small amounts of IL-12 p40 (Table 1) . However, unlike LPS, stimulation through hOSCAR did not induce secretion of significant amounts of IL-1β, IL-6, IL-10, IL-12 p70, TNF, and GM-CSF (Table 1 ). Significant amounts of MCP-1/CCL2 and MDC/CCL22, but not IP10/CXCL10 were detected in the supernatants of hOSCAR-stimulated mono-DC.
In order to determine the type of chemokines induced upon hOSCAR cross-linking, we assayed cDNA prepared from mono-DC incubated for 2 h with MOPC21, anti-hOSCAR and LPS using realtime semi-quantitative RTPCR (Fig. 5B) . Cross-linking of hOSCAR triggered high expression levels of TARC/CCL17 and MDC/CCL22. These chemokine attract Th2 effectors and regulatory T cells 35, 36 . In contrast to LPS, hOSCAR ligation did not induce significant transcription of MIG/CXCL9, IP10/CXCL10 and RANTES/CCL5, chemokines able to recruit Th1 T cells 35, 37 .
hOSCAR ligation modulates cytokine production by mono-DC exposed to TLR-ligands
The diversity and quantity of cytokines and chemokines produced by hOSCAR-stimulated mono-DC was more restricted than that of LPS-stimulated DC ( Table 1) . As some ITAM-signalling receptors, such as TREM-1 19, 20, 38 , synergize with other activators, we investigated the modulation of TLR-mediated cytokine secretion upon hOSCAR engagement.
Co-stimulation of the cells with anti-hOSCAR and any of the TLR-ligands used strongly augmented the secretion of IL-10 ( Fig. 6 ). This effect was dependent on PI3K signalling, as
shown by its inhibition when cells were pre-treated with LY294002. IL-12 p40 production were slightly up-regulated with poly(I:C) and R-848, while no modification was observed in combination with LPS. hOSCAR co-stimulation decreased the secretion of IL-12 p70 induced by LPS and upregulated that induced by R-848. The increase of IL-12 p70 production was dependent on the PI3K pathway, while the down-regulation observed with LPS was not altered by PI3K inhibitors. In addition, the secretion of IP10/CXCL10 upon LPS and R-848 stimulation was strongly suppressed by the ligation of hOSCAR in a PI3K-independent mechanism. Overall, only the increase of IL-10 and IL-12 p70 production induced by hOSCAR engagement was clearly PI3K-dependent, suggesting that another pathway is involved in the inhibitory activity of hOSCAR on cytokine release.
Co-stimulation by hOSCAR ligation and TLR ligands enhances the ability of mono-DC to induce allogeneic CD45RA + T cell proliferation
We tested whether anti-hOSCAR stimulation alone or in combination with other activators, triggered or enhanced the ability of mono-DC to induce allogeneic CD45RA + T cell proliferation. Anti-hOSCAR-treated mono-DC did not promote a significant CD45RA + naive T cell proliferation (Fig. 7A) . When the mono-DC were stimulated by both anti-hOSCAR and TLR ligands (LPS, poly(I:C) and R-848), T cell proliferation was enhanced compared to that induced by mono-DC treated with the TLR-ligands only (Fig. 7B ). This effect was particularly strong with LPS and R-848. No synergy was observed with TNF-stimulation.
We production and the effect on IFN-γ production, in addition to intra-cellular cytokine staining, were confirmed by measuring cytokine secretion by ELISA (Fig. 7D) .
DISCUSSION
Recently we and others 22, 23, 25 Bcl-2, Bcl-x L expression 42 . We have shown that the anti-apoptotic effects of hOSCAR-stimulation in mono-DC are dependent on both PI3K and ERK pathways. In other cell types growth factor-induced cell survival has been shown to be due to PI3K that through 35, 37 . These data suggest that hOSCAR engagement alone preferentially triggers the production of chemokines recruiting Th2 and regulatory cells. 
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